The pharmaceutical industry in Belgium - Competitiveness analysis [09/05/2019]

This Working Paper analyses the competitive position of the pharmaceutical industry over the 2000-2017 period. The evolution of price/cost competitiveness and non-cost competitiveness is studied based on a comparison with our neighbouring countries France, the Netherlands and Germany, and with Denmark, Ireland, Slovenia and Switzerland. The study also analyses a series of global factors and factors specific to the pharmaceutical industry that may influence competitiveness.

Tax incentives for business R&D in Belgium - Third evaluation [07/05/2019]

Belgium has committed to raise investment in research and development (R&D) to 3% of GDP by 2020. In fulfilment of this commitment, the federal government introduced different tax incentives in support of business R&D. This paper presents the results of the third evaluation of the efficiency of these tax incentives, covering the period 2003-2015.

Value chain integration of export-oriented and domestic market manufacturing firms - An analysis based on a heterogeneous input-output table for Belgium [26/09/2018]

This working paper presents a breakdown of manufacturing industries in the 2010 Belgian input-output tables into export-oriented and domestic market firms. Analyses based on these tables show that export-oriented manufacturers generate a substantial amount of value added in other Belgian firms through their exports. Hence, in terms of policy, export promotion must take into account the value chain for producing exports.

Economic impact of professional services reform in Belgium - A DSGE simulation [05/07/2018]

This working paper analyses the economic impact of a regulated professional services reform in Belgium through simulations based on the European Commission’s DSGE model QUEST III R&D